Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Saverio Mantuano"'
Autor:
Nicola Cascavilla, Felicina Li Gioi, Giuseppina Ricciuti, Maurizio Musso, Alessandra Crescimanno, Ferdinando Porretto, Gaetano De Santis, Emilio Iannitto, Annalisa Chiarenza, Ugo Consoli, Attilio Guarini, Maria Cristina Pirosa, Antonino Greco, Giuseppe Tarantini, Marilena Salerno, Saverio Mantuano, Carla Minoia, Donato Mannina, Francesco Di Raimondo, Alessandra Romano, Potito Rosario Scalzulli, Enzo Pavone, Renato Scalone, Anastasia Laura Caruso, Vincenza Bonanno
Publikováno v:
European journal of haematologyREFERENCES. 104(6)
Objective and methods In order to assess the efficacy of brentuximab vedotin (Bv) in combination with bendamustine (B) in multiple relapsed or refractory (RR) classic Hodgkin lymphoma (cHL), medical records of 47 patients treated with BvB in second r
Autor:
Anna Lucania, Antonio La Sala, Giovanni D'Arena, Francesco Saverio Mantuano, Lucia Mastrullo, Eustachio Miraglia, Cascavilla Nicola, Matteo Dell’Olio, Scalzulli Rp, Michele Nobile, Grazia Sanpaolo
Publikováno v:
Leukemia & Lymphoma. 52:1222-1229
The incidence of non-Hodgkin lymphomas increases with age. Non-pegylated liposomal formulations of doxorubicin (Myocet®) reduce systemic and cardiac toxicity especially in the elderly, who often have cardiac diseases. We treated 80 patients (mean ag
Autor:
Nicola Cascavilla, Saverio Mantuano, Lucia Mastrullo, Giovanni D'Arena, Antonio Abbadessa, Maria Rosaria Villa, Matteo Dell’Olio, Antonio La Sala, Maria Luigia Vigliotti, Potito Rosario Scalzulli
Publikováno v:
European Journal of Haematology. 82:235-239
We report four patients (mean age 65 yr; range 40-77 yr) affected by acquired pure red cell aplasia (PRCA) complicating chronic lymphoid disorders and treated with anti-CD20 monoclonal antibody rituximab. Three out of four patients were given packed
Autor:
Nicola Cascavilla, Carlo Bodenizza, Antonietta Falcone, Matteo Dell’Olio, Pellegrino Musto, Saverio Mantuano, Michele Nobile, Lorella Melillo, Angelo Michele Carella, Grazia Sanpaolo, Potito Rosario Scalzulli, Antonio La Sala
Publikováno v:
Leukemia & Lymphoma. 44:1545-1548
Ninety patients with untreated, stage I-II A myeloma, were randomised to receive or not monthly infusions of pamidronate (PMD) for 1 year, without additional therapies. Follow-up ranged from 36 to 72 months (median 51 months). Three years after the s
Autor:
Pellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, Tommasina Guglielmelli, Renato Zambello, Enrico Balleari, Lucio Catalano, Mauro Spriano, Federica Cavallo, Antonio La Sala, Saverio Mantuano, Michele Nobile, Lorella Melillo, Potito Rosario Scalzulli, Matteo Dell’Olio, Carlo Bodenizza, Michele Mario Greco, Angelo Michele Carella, Emanuela Merla, Mario Boccadoro, Nicola Cascavilla, Antonio Palumbo
Publikováno v:
Leukemia research. 30(3)
Twenty-one patients with multiple myeloma, all relapsed after frontline autologous stem cell transplantation and all relapsed again after or resistant to thalidomide (employed as second line treatment) received bortezomib (1.3 mg/m(2) body surface tw
Autor:
Lorella Melillo, Antonio La Sala, Michele Nobile, Antonietta Falcone, Michele Mario Greco, Silvana Capalbo, Grazia Sanpaolo, Nicola Cascavilla, Carlo Bodenizza, Matteo Dell' Olio, Emanuela Merla, Gian Paolo Rossi, Potito Rosario Scalzulli, Angelo Michele Carella, Saverio Mantuano
Publikováno v:
Blood. 120:5032-5032
Abstract 5032 Introduction. Combining bortezomib with pegylated liposomal doxorubicin for the treatment of Multiple Myeloma (MM) may reciprocally increase their efficacy in vitro and appears to offer higher overall response rates in vivo. With the ai
Autor:
Matteo Scaramuzzi, Grazia Sanpaolo, Lorella Melillo, Carlo Bodenizza, Nicola Cascavilla, Michele Mario Greco, Antonietta Falcone, Matteo Dell’Olio, Giovanni D'Arena, Potito Rosario Scalzulli, Francesco Saverio Mantuano, Angelo Michele Carella, Emanuela Merla, Michele Nobile, Pierluigi Di Sebastiano, Angelo Ambrosio, Giovanni Rossi, Antonio La Sala
Publikováno v:
Blood. 112:4548-4548
Background: Despite the popularity of splenectomy has decreased dramatically in the past few years, the surgical approach remains the best therapy for patients with refractory Immune Thrombocytopenic Purpura (ITP) in terms of high and durable rate of
Autor:
Sanpaolo G. Sanpaolo, Potito Rosario Scalzulli, Francesco Saverio Mantuano, Antonio La Sala, Nicola Cascavilla, Maria Rosa Valvano, Antonietta Falcone, Matteo Dell’Olio, Michele Nobile, Michele Mario Greco, Carlo C. Bodenizza, Lorella Melillo, Angelo Michele Carella, Emanuela Merla
Publikováno v:
Blood. 110:5117-5117
Background: Autologous Transplantation with intermediate or high doses of Melphalan is the most effective therapy in patients with Multiple Myeloma being < 65 years old, although this procedure is limited by an high percentage of relapses. Recent adv
Autor:
Nicola Cascavilla, Grazia Sanpaolo, Potito Rosario Scalzulli, Saverio Mantuano, Lorella Melillo, Angelo Michele Carella, Michele Nobile, Antonietta Falcone, Matteo Dell’Olio, Emanuela Merla, Michele Mario Greco, Antonio La Sala, Carlo Bodenizza
Publikováno v:
Blood. 110:4380-4380
The role of ASCT in AML appears to be appropriate in patients with favorable cytogenetic features whereas allogeneic SCT is appropriate in those with high-risk cytogenetic features. Gemtuzumab ozogamicin (GO), a monoclonal antibody conjugated to the
Autor:
Nicola Cascavilla, Lorella Melillo, Grazia Sanpaolo, Antonio La Sala, Angelo Michele Carella, Michele Nobile, Michele Mario Greco, Saverio Mantuano, Potito Rosario Scalzulli, Emanuela Merla, Carlo Bodenizza, Antonietta Falcone, Matteo Dell’Olio
Publikováno v:
Blood. 108:4677-4677
The Lymphomatous Meningitis (LM) is an uncommon event, either as an initial diagnosis and in the course (or as an outcome) of a front line treatment. In the latter cases the LM has a poor prognosis and a median survival of few months in untreated pat